SEP 10, 2026 · PHASE 2 TRIAL
Neoadjuvant Culmerciclib Combined With Endocrine Therapy for Hormone Receptor-Positive， Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer
ClinicalTrials.gov
This is a planned Phase 2 trial with no results posted; it describes the protocol and primary endpoint only, making it preliminary evidence at best once data become available.
Reported
Planned enrollment80
Study phasePhase 2
Primary outcome measureRate of participants achieving Residual Can…